Pfizer completes Haleon exit with £2.5bn stake sale
Pfizer has raised £2.5 billion by offloading its remaining 7.3% stake in Haleon, the Panadol and Sensodyne business it used ...
Pfizer offloads final shares in Sensodyne maker Haleon
Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...
Pfizer sells entire Haleon stake for $3.24 billion
Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...
AllAfrica on MSN2d
Kenya: GSK Rebrands to Haleon Kenya After Separation
Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025. The rebrand comes after GSK transferred its consumer health business to Haleon to ...
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...
City snapshot: Pfizer completes £2.5bn Haleon exit
Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.
German Doner Kebab boss wants to turn chain into date-worthy dinner spot
GERMAN DONER KEBAB boss Simon Wallis is on a mission to transform the food from “something you eat at 2am after 12 pints of ...
Pfizer to Dispose of Remaining Shareholding in Haleon
Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...